Lindbrook Capital »

Verve Therapeutics shares owned by Lindbrook Capital

Quarter-by-quarter ownership of Verve Therapeutics (VERV) shares owned by Lindbrook Capital from 13F filings

Historical chart of Lindbrook Capital investment in Verve Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Verve Therapeutics held by Lindbrook Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Verve Therapeutics by Lindbrook Capital

Quarter filed Position value Share count Share price at filing
2024-03-31 $4.1k 311 13.28
2023-12-31 $5.9k 422 13.94
2023-09-30 $1.2k 90 13.26
2022-09-30 $1.0k 38 26.32
2021-06-30 $18k 300 60.00